source
- US proposes new biotech investment limits on China, but licensing deals remain allowedThe U.S. Treasury announced a proposal to curb outbound investments in Chinese biotechnology, citing national‑security concerns. The plan would limit U.S. persons from funding certain bio‑derived c…
- FDA lifts hold on Aardvark Therapeutics' ARD-101 after safety study shows no cardiac eventsFDA has lifted the clinical hold on Aardvark Therapeutics' ARD-101 after the company completed an additional safety study. The new data showed no cardiac events, addressing the concerns that prompt…